Atlas Trials

Study of 18 mg Selincro® As-needed Use, in the Treatment of Patients With Alcohol Dependence in Primary Care

Clinical trial NCT02195817 · TERMINATED

Trial details

NCT number
NCT02195817
Sponsor
H. Lundbeck A/S
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Alcohol Dependence
Start date
2014-08-01
Primary completion
2016-02-01
Enrollment
378

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.